Skip to main content
Clinical Trials/CTRI/2022/04/042249
CTRI/2022/04/042249
Completed
未知

Comparison of the efficacy of Intranasal Atomised Dexmedetomidine versus Intranasal Atomised ketamine as a premedicant for anxiolysis and sedation in paediatric population aged 1-10 years undergoing spinal dysraphism surgery - a randomised double blinded controlled trial.

Ankur Luthra0 sites64 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Ankur Luthra
Enrollment
64
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
December 14, 2022
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 64 ASA I and II children aged between 1\-10years scheduled for spinal dysraphism surgery will be enrolled in this study.

Exclusion Criteria

  • Refusal of consent
  • Known allergy to dexmedetomidine or ketamine
  • ASA III or IV
  • Children with cardiac anomalies
  • Children with seizures
  • Children with upper respiratory tract infection
  • Children with liver disease
  • Children with mental retardation
  • Difficult cannulation (three or more attempts)

Outcomes

Primary Outcomes

Not specified

Similar Trials